Literature DB >> 29410024

DNA methylation profiling in nonfunctioning pituitary adenomas.

Paulina Kober1, Joanna Boresowicz2, Nataliia Rusetska1, Maria Maksymowicz3, Krzysztof Goryca4, Jacek Kunicki5, Wiesław Bonicki5, Janusz Aleksander Siedlecki1, Mateusz Bujko6.   

Abstract

Nonfunctioning pituitary adenomas (NFPAs) are among the most frequent intracranial tumors but their molecular background, including changes in epigenetic regulation, remains poorly understood. We performed genome-wide DNA methylation profiling of 34 NFPAs and normal pituitary samples. Methylation status of the selected genomic regions and expression level of corresponding genes were assessed in a group of 75 patients. NFPAs exhibited distinct global methylation profile as compared to normal pituitary. Aberrant DNA methylation appears to contribute to deregulation of the cancer-related pathways as shown by preliminary functional analysis. Promoter hypermethylation and decreased expression level of SFN, STAT5A, DUSP1, PTPRE and FGFR2 was confirmed in the enlarged group of NFPAs. Difference in the methylation profiles between invasive and non-invasive NFPAs is very slight. Nevertheless, invasiveness-related aberrant epigenetic deregulation of the particular genes was found including upregulation of ITPKB and downregulation CNKSR1 in invasive tumors.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenoma; DNA methylation; Epigenetics; Gene expression; NFPA; Pituitary

Mesh:

Year:  2018        PMID: 29410024     DOI: 10.1016/j.mce.2018.01.020

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

Review 1.  Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies.

Authors:  Busra Aydin; Aysegul Caliskan; Kazim Yalcin Arga
Journal:  EPMA J       Date:  2021-06-26       Impact factor: 8.836

Review 2.  Aggressive nonfunctioning pituitary neuroendocrine tumors.

Authors:  Sérgio Portovedo; Leonardo Vieira Neto; Christina Maeda Takiya; Leandro Miranda-Alves; Paula Soares; Denise Pires de Carvalho
Journal:  Brain Tumor Pathol       Date:  2022-06-20       Impact factor: 3.154

3.  DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.

Authors:  Maritza S Mosella; Thais S Sabedot; Tiago C Silva; Tathiane M Malta; Felipe Segato Dezem; Karam P Asmaro; Michael Wells; Abir Mukherjee; Laila M Poisson; James Snyder; Ana C deCarvalho; Tobias Walbert; Todd Aho; Steven Kalkanis; Paula C Elias; Sonir R Antonini; Jack Rock; Houtan Noushmehr; Margaret Castro; Ana Valeria Castro
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

4.  Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.

Authors:  Grayson A Herrgott; Karam P Asmaro; Michael Wells; Thais S Sabedot; Tathiane M Malta; Maritza S Mosella; Kevin Nelson; Lisa Scarpace; Jill S Barnholtz-Sloan; Andrew E Sloan; Warren R Selman; Ana C deCarvalho; Laila M Poisson; Abir Mukherjee; Adam M Robin; Ian Y Lee; James Snyder; Tobias Walbert; Mark Rosenblum; Tom Mikkelsen; Arti Bhan; John Craig; Steven Kalkanis; Jack Rock; Houtan Noushmehr; Ana Valeria Castro
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

5.  The Role of Aberrant DNA Methylation in Misregulation of Gene Expression in Gonadotroph Nonfunctioning Pituitary Tumors.

Authors:  Paulina Kober; Joanna Boresowicz; Natalia Rusetska; Maria Maksymowicz; Agnieszka Paziewska; Michalina Dąbrowska; Jacek Kunicki; Wiesław Bonicki; Jerzy Ostrowski; Janusz A Siedlecki; Mateusz Bujko
Journal:  Cancers (Basel)       Date:  2019-10-25       Impact factor: 6.639

6.  Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma.

Authors:  Sen Cheng; Chuzhong Li; Weiyan Xie; Yazhou Miao; Jing Guo; Jichao Wang; Yazhuo Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-03       Impact factor: 5.682

7.  Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas.

Authors:  Yiwen Xu; Yamei Niu; Kan Deng; Hui Pan; Feng Feng; Fengying Gong; Wei-Min Tong; Shi Chen; Lin Lu; Renzhi Wang; Hui You; Yong Yao; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

8.  DNA Methylation Influences miRNA Expression in Gonadotroph Pituitary Tumors.

Authors:  Joanna Boresowicz; Paulina Kober; Natalia Rusetska; Maria Maksymowicz; Agnieszka Paziewska; Michalina Dąbrowska; Natalia Zeber-Lubecka; Jacek Kunicki; Wiesław Bonicki; Jerzy Ostrowski; Janusz A Siedlecki; Mateusz Bujko
Journal:  Life (Basel)       Date:  2020-05-13

9.  FGFR2 gene polymorphism rs2981582 is associated with non-functioning pituitary adenomas in Chinese Han population: a case-control study.

Authors:  Bin Zhu; Juan Wang; Lingling Qin; Lei Wang; Yanfei Zheng; Lei Zhang; Wei Wang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

10.  Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles.

Authors:  Sen Cheng; Weiyan Xie; Yazhou Miao; Jing Guo; Jichao Wang; Chuzhong Li; Yazhuo Zhang
Journal:  J Transl Med       Date:  2019-12-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.